Clincosm LogoSign in Get a demo

lymphoma, malignant

Showing 1 - 14 of 14
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Lymphoma Diagnosed at Nimes University Hospital From 1999 to

Recruiting
  • Lymphoma, Malignant
    • Nîmes, France
      CHU Nimes
    May 12, 2022

    Solid Tumor, Lymphoma, Malignant Trial in Beijing, Changsha, Guang Zhou (Enzastaurin)

    Completed
    Has Results
    • Solid Tumor
    • Lymphoma, Malignant
    • Beijing, China
    • +2 more
    Sep 14, 2020

    Solid Tumor, Lymphoma, Malignant Trial in France (warfarin, enzastaurin)

    Completed
    Has Results
    • Solid Tumor
    • Lymphoma, Malignant
    • Bordeaux, France
    • +6 more
    Jun 9, 2020

    Lymphoma, Malignant Trial in Germany (Rituximab)

    Completed
    • Lymphoma, Malignant
    • Berlin, Germany
    • +16 more
    Jan 2, 2020

    Lymphoma, Malignant Trial in Worldwide (bimiralisib)

    Completed
    • Lymphoma, Malignant
    • New York, New York
    • +11 more
    Aug 27, 2019

    Lymphoma, Large B-Cell, Diffuse, Lymphoma, Mantle-Cell, Lymphoma, Follicular Trial in Argentina, United States (ASN002 Dose

    Terminated
    • Lymphoma, Large B-Cell, Diffuse
    • +20 more
    • ASN002 Dose Escalation
    • ASN002 RD
    • Tempe, Arizona
    • +13 more
    Aug 13, 2018

    Lymphoma, Malignant, Advanced Solid Tumors Trial in New Haven, Detroit, Bronx (TAK-659)

    Withdrawn
    • Lymphoma, Malignant
    • Advanced Solid Neoplasms
    • New Haven, Connecticut
    • +2 more
    Mar 26, 2018

    Tumors, Carcinoma, Bronchogenic, Breast Carcinoma Trial in Wuxi (18F-Al-NOTA-PRGD2 PET/CT)

    Unknown status
    • Tumors
    • +5 more
    • 18F-Al-NOTA-PRGD2 PET/CT
    • Wuxi, Jiangsu, China
      Wuxi No. 4 People's Hospital
    Mar 9, 2017

    Myeloma, Plasma-Cell, Lymphoma, Malignant Trial in Kansas City (Palonosetron, Aprepitant, Dexamethasone)

    Completed
    Has Results
    • Myeloma, Plasma-Cell
    • Lymphoma, Malignant
    • Kansas City, Kansas
      University of Kansas Medical Center
    Jan 18, 2017

    Tumors, Lymphoma, Malignant Trial in San Antonio (E7820)

    Completed
    • Neoplasms
    • Lymphoma, Malignant
    • San Antonio, Texas
      (unnamed)
    Dec 19, 2014

    Myeloma, Plasma-Cell, Lymphoma, Malignant, Myeloproliferative Disorders Trial in Ann Arbor (Reduced intensity conditioning with

    Completed
    • Myeloma, Plasma-Cell
    • +4 more
    • Reduced intensity conditioning with allogeneic transplant
    • Ann Arbor, Michigan
      The University of Michigan
    Aug 7, 2012

    Lymphoma, Malignant, Hodgkin's Lymphoma, B Cell Lymphoma Trial in Houston (SB1518)

    Completed
    • Lymphoma, Malignant
    • +2 more
    • Houston, Texas
      MD Anderson Cancer Center
    Apr 19, 2012

    Leukemia, Myelogenous, Chronic, Leukemia, Lymphoblastic, Acute, Leukemia, Myelogenous, Acute Trial in Chicago (drug, other,

    Unknown status
    • Leukemia, Myelogenous, Chronic
    • +4 more
    • Myeloablative Chemotherapy Regimen for Lymphoid Malignancies or Cord Blood Unit Recipients
    • +3 more
    • Chicago, Illinois
      Children's Memorial Hospital
    Mar 29, 2011

    Tumors, Thrombocytopenia, Multiple Myeloma Trial in Argentina, Mexico, United States ((PN-152,243)/PN-196,444)

    Completed
    • Neoplasms
    • +3 more
    • Berkeley, California
    • +8 more
    Nov 8, 2006